Royal Bank of Canada »

Blueprint Medicines shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 17k 95.59
2024-06-30 $956k 8.9k 107.61
2024-03-31 $431k 4.5k 96.00
2023-12-31 $2.0M 22k 92.28
2023-09-30 $527k 11k 47.62
2023-06-30 $436k 6.9k 63.14
2022-12-31 $535k 12k 43.68
2022-09-30 $246k 3.7k 65.76
2021-06-30 $2.0M 26k 76.92
2021-03-31 $5.2M 54k 97.37
2020-12-31 $6.3M 56k 112.29
2020-09-30 $5.2M 56k 92.77
2020-06-30 $5.5M 71k 78.13
2020-03-31 $4.0M 69k 58.14
2019-12-31 $623k 7.8k 79.99
2019-09-30 $235k 3.2k 73.39
2019-03-31 $2.3M 28k 80.36
2018-12-31 $5.8M 110k 52.63
2018-09-30 $8.1M 104k 77.73
2018-06-30 $4.7M 75k 62.07
2018-03-31 $5.0k 53 94.34
2017-12-31 $22k 312 68.97
2016-12-31 $23k 827 27.88
2015-12-31 $0 13 0.00
2015-09-30 $9.0k 419 21.48